Dustin Gayheart, MD
Urology · Pikeville, KYNPI 1063730372
Payments from drug & device makers
Across 118 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$412
- Procept Biorobotics Corporation$271
- Merck$165
- Urogen Pharma, Inc.$165
- Takeda Pharmaceuticals U.S.A., Inc.$151
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$107
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,292100%
- Education$50%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 15 | $412 |
| Procept Biorobotics Corporation | 6 | $271 |
| Merck | 9 | $165 |
| Urogen Pharma, Inc. | 14 | $165 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $151 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $107 |
| Johnson & Johnson(2 entities) | 5 | $104 |
| EDAP Technomed Inc | 6 | $93 |
| C. R. Bard, Inc. & Subsidiaries | 4 | $84 |
| Endo USA, Inc. | 3 | $69 |
| Nestle Healthcare Nutrition Inc. | 5 | $64 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| AbbVie | 4 | $62 |
| Madrigal Pharmaceuticals | 3 | $50 |
| Daiichi Sankyo Inc. | 3 | $49 |
| Progenics Pharmaceuticals, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $42 |
| Valencia Technologies Corporation | 1 | $34 |
| Tolmar Pharmaceuticals, Inc. | 1 | $24 |
| Olympus America Inc. | 1 | $19 |
| Integra Lifesciences Corporation | 1 | $18 |
| Pfizer | 1 | $18 |
| Ardelyx, Inc. | 1 | $18 |
| ABC Home Medical Supply, Inc. | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
| Bard Access Systems, Inc. | 1 | $16 |
| Smith+Nephew | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Novartis | 1 | $15 |
| Bayer | 1 | $15 |
| Cook Medical LLC | 1 | $15 |
| Dentsply IH AB | 1 | $13 |
| Palette Life Sciences, Inc. | 1 | $13 |
| CSL Behring | 1 | $12 |
| Vivus LLC | 1 | $11 |
How this compares
$2,298 in reported general payments places this provider in the 45th percentile of 139 urology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 72 | $43,268 |
| GemtesaVibegron | 23 | $12,614 |
| Testosterone Cypionate | 273 | $6,954 |
| Tamsulosin Hcl | 604 | $4,772 |
| Methenamine Hippurate | 66 | $4,126 |
| Finasteride | 278 | $1,673 |
| Testosterone | 12 | $1,628 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 75 | $1,124 |
| Estradiol | 11 | $904 |
| Gentamicin Sulfate | 11 | $706 |
| Dutasteride | 43 | $593 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $365 |
| Oxybutynin Chloride ErOxybutynin Chloride | 17 | $146 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 77 | $110 |
| Sildenafil Citrate | 20 | $106 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $15 | $12,61423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 139 urology providers in Kentucky.
Other urology in Pikeville
- Jasgurpreet SinghPikeville$4K
- Patrick HensleyLexington$153K
- Thomas SlabaughLexington$102K
- Uzoma AneleLouisville$60K
- Lee EvansHopkinsville$56K
- Brooke EdwardsCrestview Hills$45K
- James AngelLexington$32K
- Meredith AngelCampbellsville$30K
- Robert LarkeCrestview Hills$22K
- Stephen MonnigLexington$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.